SCHEMBL2456077

SCHEMBL2456077

c1cc2ccc(-c3ccon3)cc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
BRD4 O60885 2/20 0.51
APP P05067 1/20 0.43
AHR P35869 3/20 0.43
CMA1 P23946 1/20 0.43
TYR P14679 1/20 0.43
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
S1PR1 P21453 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA10 Q9GZZ6 1/20 0.40
CHRNA9 Q9UGM1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455118 0.86 NPC1 (0.51) NPC1RAB9ABRD4APPAHR
SCHEMBL2462066 0.77 FGFR1 (0.54) NPC1RAB9AMEN1MAPK1KMT2A
SCHEMBL2459152 0.75 BRD4 (0.50) BRD4APPAHRCMA1TYR
SCHEMBL2463860 0.73 BRD4 (0.49) BRD4APPAHRCMA1TYR
SCHEMBL29696597 0.73 NPC1 (0.65) NPC1RAB9ACYP1A2CYP2D6CYP19A1
SCHEMBL4059081 0.72 CYP1A2 (0.57) NPC1RAB9ACYP1A2CYP2D6CYP19A1
SCHEMBL27361728 0.71 BRD4 (0.46) BRD4APPAHRCMA1TYR
SCHEMBL2455111 0.71 BRD4 (0.47) NPC1BRD4APPAHRCMA1
SCHEMBL2459898 0.71 BRD4 (0.52) NPC1RAB9ABRD4S1PR1KDM4E
SCHEMBL2462362 0.70 BRD4 (0.45) NPC1BRD4APPAHRCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed
CN-1268352-A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole LILLY CO ELI (US) 2000-10-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET NPC1 1244/4885RAB9A 3044/4885BRD4 3654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.